Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Baglin

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Blood|March 7, 1998
Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein CD Williamson, K Brown, R Luddington, et al.
British Journal of Haematology|December 31, 1997
Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?J Peters, R Luddington, K Brown, et al.
Thrombosis and Haemostasis|March 30, 2000
The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein CR Luddington, A Jackson, S Pannerselvam, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2013
Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertainL Yang, A Vuylsteke, C Gerrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Bacterial endocarditis in a child with haemophilia B: risks of central venous cathetersD K Hothi, W Kelsall, T Baglin, et al.
British Journal of Haematology|December 21, 2000
Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolismA Jackson, K Brown, J Langdown, et al.
British Journal of Haematology|November 5, 1997
Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin geneK Brown, R Luddington, D Williamson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2017
Analysis of pulmonary embolus size at the time of recurrence compared with presentation: a single-centre retrospective studyW Thomas, O Firth, M Besser, et al.
Blood|May 26, 1999
Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteinsJ Taube, N McWilliam, R Luddington, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2012
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTHT Baglin, K Bauer, J Douketis, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Blood|March 7, 1998
Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein CD Williamson, K Brown, R Luddington, et al.
British Journal of Haematology|December 31, 1997
Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?J Peters, R Luddington, K Brown, et al.
Thrombosis and Haemostasis|March 30, 2000
The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein CR Luddington, A Jackson, S Pannerselvam, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2013
Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertainL Yang, A Vuylsteke, C Gerrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Bacterial endocarditis in a child with haemophilia B: risks of central venous cathetersD K Hothi, W Kelsall, T Baglin, et al.
British Journal of Haematology|December 21, 2000
Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolismA Jackson, K Brown, J Langdown, et al.
British Journal of Haematology|November 5, 1997
Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin geneK Brown, R Luddington, D Williamson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2017
Analysis of pulmonary embolus size at the time of recurrence compared with presentation: a single-centre retrospective studyW Thomas, O Firth, M Besser, et al.
Blood|May 26, 1999
Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteinsJ Taube, N McWilliam, R Luddington, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2012
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTHT Baglin, K Bauer, J Douketis, et al.
Pageof 8